Extendicare (OTCMKTS:EXETF – Get Free Report) is expected to release its results after the market closes on Thursday, November 5th. Analysts expect Extendicare to announce earnings of $0.25 per share and revenue of $446.58 million for the quarter.
Extendicare Price Performance
OTCMKTS:EXETF opened at $19.53 on Thursday. Extendicare has a 1-year low of $11.06 and a 1-year high of $28.45. The business’s 50-day moving average price is $21.05 and its two-hundred day moving average price is $21.49.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on EXETF shares. Royal Bank Of Canada reissued an “outperform” rating on shares of Extendicare in a research report on Friday, August 14th. Canadian Imperial Bank of Commerce reiterated an “outperform” rating on shares of Extendicare in a report on Monday. Five research analysts have rated the stock with a Buy rating. According to data from MarketBeat, the company presently has a consensus rating of “Buy”.
Read Our Latest Research Report on EXETF
Extendicare Company Profile
Extendicare Inc is a Canadian provider of healthcare and support services for seniors. The company operates long-term care homes and retirement communities, serving residents who require assisted living, complex care, rehabilitation, and other continuing-care services.
Extendicare also provides home healthcare through its ParaMed business. These services include nursing, personal support, rehabilitation, and other care delivered in patients’ homes, helping individuals maintain independence and supporting families and caregivers.
The company’s operations are primarily focused on Canada, with a presence in several provinces, including Ontario and Western Canada.
Featured Articles
- Five stocks we like better than Extendicare
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
